Merck KGaA MKGAF
167.45 USD -1.76 (-1.04%)
Nov 3, 2026, 3:54 PM EST
167.45 Day range 167.45
116.68 52-week range 175.56
- YTD
- +13.45%
- 1 year
- +29.71%
- Market cap
- 72.80B
- EPS (ttm)
- 6.36
- P/E ratio
- 26.33
- YTD return
- +13.45%
- 1-year return
- +29.71%
- Volume
- 93
- Avg volume
- 656
- Open
- 167.45
- Previous close
- 169.21
- Day's range
- 167.45 – 167.45
- 52-week range
- 116.68 – 175.56
- Earnings date
- Nov 12, 2026
2Y +3.30 (+2.01%)
Next earnings
Nov 12, 2026
Expected Nov 12, 2026. Consensus EPS estimate 2.35.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2026 | Sep 30, 2026 | 2.35 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 2.38 | — | — | — |
| May 13, 2026 | Mar 31, 2026 | 2.25 | 2.44 | +0.19 | +8.44% |
| Mar 5, 2026 | Dec 31, 2025 | 2.29 | 2.21 | -0.08 | -3.49% |
| Nov 12, 2025 | Sep 30, 2025 | 2.59 | 2.42 | -0.17 | -6.56% |
| Aug 7, 2025 | Jun 30, 2025 | 2.52 | 1.77 | -0.75 | -29.76% |
News
Why Is Silence Therapeutics Stock Skyrocketing Monday? 
Germany's Merck to Buy U.K. Biotech Silence Therapeutics for $1.3 Billion 
Merck KGaA (OTCMKTS:MKGAF) Shares Gap Down – Should You Sell? 
363,066 Shares in Merck KGaA $MKGAF Purchased by Beacon Pointe Advisors LLC 
Blue Edge Capital LLC Decreases Stake in Merck KGaA $MKGAF 
Bamco Inc. NY Buys Shares of 22,000 Merck KGaA $MKGAF 
ADAR1 Capital Management LLC Invests $403,000 in Merck KGaA $MKGAF 
Ancora Advisors LLC Invests $2.69 Million in Merck KGaA $MKGAF 
Ausdal Financial Partners Inc. Takes Position in Merck KGaA $MKGAF 
AFT Forsyth & Company Inc. Invests $822,000 in Merck KGaA $MKGAF
Your note
Sign in to keep a note on MKGAF — it syncs with the Stock Master app.